Thus, PPI metabolism is influenced by CYP2C19 polymorphisms, which influence treatment outcomes in patients with peptic ulcer disease (Klotz et al. 2004; Kurzawski et al. 2006). Here, CYP2C19 is linked to peptic ulcer disease.